Eloralintide Lilly's Amylin Agonist Outperforms Novo's Cagrilintide at 48 Weeks Amylin Injectable Cagrilintide Demonstrates Weight Loss of 11.8% in Late Stage Trial: Novo Nordisk Update Patient Care Online Cagrilintide Semaglutide 2.4 2.4 Or 5 5 NuScience Peptides Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial The Lancet Efficacy and safety of co administered once weekly cagrilintide 24 mg with once weekly semaglutide 24 mg in type 2 diabetes: a multicentre, randomised, double blind, active controlled, phase 2 trial The Lancet Cagrilintide Weight Loss Appetite Control and Fat Burning Support